Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin and Exenatide in Obese PCOS
NCT02635386Phase 3Completed
- Sponsor
- Woman's
- Start
- Mar 2016
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in polycystic ovary syndrome (PCOS), sponsored by Woman's. Started Mar 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02635386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02635386.